Brandywine Financial Group’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$14.3K Hold
500
– – 0.01% 48
2026
Q2
$12K Hold
500
– – 0.14% 12
2026
Q1
$14K Hold
500
– – 0.01% 24
2025
Q4
$12.4K Buy
+500
New +$12.6K 0.03% 32

Other funds holding PFE

Brandywine Financial Group's PFE Position: Q3 2026 in Review

Brandywine Financial Group held its Pfizer (PFE) position steady in Q3 2026 at 500 shares worth $14.3K. The position accounts for 0.01% of the portfolio, ranked #48.

Brandywine Financial Group first reported a position in PFE in Q4 2025 and has held it in 4 quarters since. 1,861 funds tracked by Wall St. Rank hold PFE as of Q3 2026.

  • Brandywine Financial Group held 500 shares of Pfizer worth $14.3K as of Q3 2026.
  • Brandywine Financial Group left its Pfizer share count unchanged in Q3 2026.
  • Pfizer made up 0.01% of Brandywine Financial Group's portfolio in Q3 2026, its #48 holding.
  • Brandywine Financial Group first reported a position in Pfizer in Q4 2025 and has held it in 4 quarters since.
  • 1,861 funds tracked by Wall St. Rank held Pfizer as of Q3 2026.

Based on Brandywine Financial Group's 13F filing for Q3 2026, filed 3 Nov 2026.